- Home
- TECH vs CELH Comparison
TECH vs CELH Comparison
Compare TECH & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TECH | CELH |
|---|---|---|
| Founded | 1976 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.1B |
| IPO Year | 1989 | N/A |
Fundamental Metrics
Financial Performance| Metric | TECH | CELH |
|---|---|---|
| Price | $67.01 | $52.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 18 |
| Target Price | ★ $70.46 | $63.41 |
| AVG Volume (30 Days) | 1.6M | ★ 4.5M |
| Earning Date | 02-04-2026 | 02-19-2026 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.49 | 0.13 |
| Revenue | $1,216,732,000.00 | ★ $2,125,838,000.00 |
| Revenue This Year | $2.33 | $82.94 |
| Revenue Next Year | $7.05 | $32.22 |
| P/E Ratio | ★ $136.75 | $422.39 |
| Revenue Growth | 3.85 | ★ 55.07 |
| 52 Week Low | $46.01 | $21.10 |
| 52 Week High | $79.28 | $66.74 |
Technical Indicators
Market Signals| Indicator | TECH | CELH |
|---|---|---|
| Relative Strength Index (RSI) | 71.77 | 70.89 |
| Support Level | $63.39 | $45.46 |
| Resistance Level | $66.48 | $54.28 |
| Average True Range (ATR) | 1.68 | 1.61 |
| MACD | 0.86 | 0.93 |
| Stochastic Oscillator | 81.13 | 83.71 |
Price Performance
Historical ComparisonAbout TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.